FDA Clearance Tracker · K172892
Neuro Assessment System NAS-1000
Last checked: Nov 20, 2026Latest source record: Mar 8, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 8, 2018
Substantially Equivalent
Time to decision
167 days
Received Sep 22, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K172892
- Device name
- Neuro Assessment System NAS-1000
- Applicant
- Headsense Medical, Inc.
- Applicant location
- Akron, OH
- Received
- Sep 22, 2017
- Decided
- Mar 8, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Cranial Sound Monitor (QBE)
- Device class
- Class II
- Regulation
- 21 CFR 870.1875
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QBE (Cranial Sound Monitor).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K172892
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Headsense Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.